Exciting opportunity to do a PhD on AMR dynamics of chronic P. aeruginosa infections with me at @sangerinstitute and Prof Craig Maclean @UniofOxford. Mainly bioinformatics but opportunities to combine with wet-lab
https://t.co/6pj1yB74yE
We are recruiting for a Post-doctoral Research Associate to conduct a human genome-wide association study of persistent colonisation by S. aureus (https://t.co/hXqgpF0S1N) in 20,000 healthy humans. Pls RT
https://t.co/S5iMVxBMXG
#job#opportunity Applications invited for a postdoctoral research position in my group in
@BiologyatYork
working on host:parasite interactions during the host immune response to Schistosoma mansoni infections #postdocjobs Deadline for application: 19/06
https://t.co/tcRysosR0G
Early bird rate for @BactiVac & @MicrobioSoc Focused Meeting 'Vaccines as tools to combat antimicrobial resistance' to be held 27–28 Feb 2023 expires on 16 Jan 2023. Book your place now to avoid disappointment - https://t.co/EJin5GSyBa. #Vaccines4AMR#BactiVacEvents
Our ICU-based study using rapid array PCR to speed up and improve diagnosis and spare antibiotic usage. Similar approaches could be used more widely. Many patients normally targeted for antibiotics show no evidence of microbial infection. @CambridgeBRC
https://t.co/cWglMU8Afu
Our new paper on the development and implementation of a novel molecular diagnostic platform for pneumonia has been published. A 🧵 here describing the main findings -TL:DR fast, accurate results which impacted on antibiotic prescribing
https://t.co/4ssMMjLV5h
We are recruiting. Are you interested in pathogen genomics of all respiratory viruses and other respiratory pathogens? Pls RT https://t.co/ReFFXD3LL0 @sangerinstitute@CovidGenomicsUK
Very happy to finally share the story of my PhD! If you’re interested in antimicrobial drug discovery and #AMR, this one’s for you! Thanks to all involved in this @Cambridge_Uni@AstraZeneca collaboration. https://t.co/H3aWmo5JoD
Many congratulations to Gavin Wright and his team on this important breakthrough. I note the coauthorship of key core @sangerinstitute technological expertise only made possible by sustained and wise investment. Key to good science. @wellcometrust
Check out our high-content imaging method - phenotyping individual bacteria at scale to study bacterial drug resistance: https://t.co/tsJtBZBCo7 @MaesMailis @Baker_Lab_Cam @GordonDougan1
🎉 Our latest paper on Mycobacterium abscessus from @flotocambridge out in Science today 🎉
https://t.co/fE0gOuekRM
How has this environmental saprophyte 🍄 adapted to humans in order to become a major problem in cystic fibrosis patients?
My favourite bits👇